Cartesian Therapeutics to Participate in the 23rd Annual Needham Virtual Healthcare Conference
Cartesian Therapeutics, Inc. (NASDAQ:RNAC) (the Company), a clinical-stage biotechnology company pioneering mRNA cell therapy for autoimmune diseases, today announced that its management expects to...